{"id":"F2016L00267","name":"Amendment Statement of Principles concerning aplastic anaemia No. 32 of 2016","slug":"amendment-statement-of-principles-concerning-aplastic-anaemia-no-32-of-2016","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":94174,"registerId":"commonwealth-F2016L00267-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Amendment Statement of Principles concerning aplastic anaemia No. 32 of 2016","content":"![RMA-Red](image.001.jpeg)\n\nAmendment Statement of Principles\n\nconcerning\n\nAPLASTIC ANAEMIA\n\nNo. 32 of 2016\n\nfor the purposes of the\n\nVeterans’ Entitlements Act 1986\n\nand\n\nMilitary Rehabilitation and Compensation Act 2004\n\n1.  This Instrument may be cited as Amendment Statement of Principles concerning aplastic anaemia No. 32 of 2016.\n2.  The Repatriation Medical Authority amends, under subsection 196B(8) of the Veterans’ Entitlements Act 1986, Statement of Principles concerning aplastic anaemia Instrument No. 51 of 2012, by:\n\n(A) Replacing existing factor \"(e)\" in clause 6 as follows:\n\n\"(e) being exposed to benzene as specified on at least 45 days within the six months before the clinical onset of aplastic anaemia; or\"; and\n\n(B) Replacing the definition of \"being exposed to benzene\" in clause 9 with the definition of \"being exposed to benzene as specified\" as follows:\n\n'\"being exposed to benzene as specified\" means:\n\n    (a) having cutaneous contact with liquids containing benzene greater than 5% by volume; or\n    (b) ingesting liquids containing benzene greater than 5% by volume; or\n    (c) inhaling benzene vapour where such exposure occurs at an ambient 8-hour time-weighted average benzene concentration exceeding five parts per million;'.\n\n3. The amendments made by this instrument apply to all matters to which Instrument No. 51 of 2012, section 120B of the Veterans’ Entitlements Act 1986 and section 339 of the Military Rehabilitation and Compensation Act 2004 apply.\n\n4. The amendments made by this instrument take effect from 4 April 2016.\n\nDated this fourth day of March 2016\n\n![](image.002.png)The Common Seal of the )\n\nRepatriation Medical Authority )\n\nwas affixed at the direction of: )\n\nPROFESSOR NICHOLAS SAUNDERS AO\n\nCHAIRPERSON","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2264},"content_quality":"ok","complexity_score":4,"scope_assessment":{"changed":false,"description":"The amendment maintains the original scope of determining service-relatedness for aplastic anaemia compensation. It refines existing criteria by adding quantitative thresholds for benzene exposure but does not expand coverage to new medical conditions, claimant groups, or statutory schemes."},"complexity_factors":["Technical chemical concentration thresholds (5% by volume, 5 parts per million)","Temporal exposure requirements (45 days within a 6-month window)","Amendments to existing delegated legislation (Statement of Principles No. 51 of 2012)","Cross-references to two primary Acts (Veterans' Entitlements Act 1986 and Military Rehabilitation and Compensation Act 2004)"],"plain_english_summary":"This instrument tightens the medical criteria for linking aplastic anaemia to service by specifying benzene exposure thresholds veterans must meet: skin/swallow contact with liquids >5% benzene, inhalation averaging >5 ppm over 8 hours, and exposure on at least 45 separate days in the six months before diagnosis.  \n\nIt affects current and former military personnel claiming under the Veterans' Entitlements Act or Military Rehabilitation and Compensation Act, clarifying that only significant, prolonged benzene exposure—not casual contact—will establish service-relatedness."}},"importantCases":[],"_links":{"self":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-32-of-2016","history":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-32-of-2016/history","analysis":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-32-of-2016/analysis","conflicts":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-32-of-2016/conflicts","importantCases":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-32-of-2016/important-cases","documents":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-32-of-2016/documents"}}